BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 26170581)

  • 21. Technical note: identifying the prostate cancer 'superscan' by quantitative skeletal scintigraphy.
    Hawkins T; Halewood MM
    Nucl Med Commun; 2008 Jul; 29(7):654-9. PubMed ID: 18528189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Visualization of discrete sacral foramina as an ancillary sign of superscan.
    Harshman LK; Latifi HR; Griffeth LK
    Clin Nucl Med; 2011 Jan; 36(1):21-4. PubMed ID: 21157202
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MIBG superscan of metastatic paraganglioma occurring with neurofibromatosis type 1.
    Harrison CE; Barron BJ
    Clin Nucl Med; 2013 Jun; 38(6):459-62. PubMed ID: 23455526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metastatic neuroblastoma: new abnormalities on bone scintigraphy may not indicate tumour recurrence.
    Hall-Craggs MA; Shaw D; Pritchard J; Gordon I
    Skeletal Radiol; 1990; 19(1):33-6. PubMed ID: 2326653
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison of whole-body turboSTIR MR imaging and planar 99mTc-methylene diphosphonate scintigraphy in the examination of patients with suspected skeletal metastases.
    Eustace S; Tello R; DeCarvalho V; Carey J; Wroblicka JT; Melhem ER; Yucel EK
    AJR Am J Roentgenol; 1997 Dec; 169(6):1655-61. PubMed ID: 9393186
    [TBL] [Abstract][Full Text] [Related]  

  • 26. (18)F-FDG-PET/CT, (123)I-MIBG and (99m)Tc-MDP whole-body scans, in detecting recurrence of an adult adrenal neuroblastoma.
    Skoura E; Oikonomopoulos G; Vasileiou S; Kyprianou D; Koumakis G; Datseris IE
    Hell J Nucl Med; 2014; 17(1):58-61. PubMed ID: 24563879
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary breast osteosarcoma: A diagnostic challenge.
    Krishnamurthy A
    Indian J Nucl Med; 2015; 30(1):39-41. PubMed ID: 25589804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Super Scan Caused by Parathyroid Carcinoma Observed Both in
    Güney İB; Paydaş S; Ballı HT
    Mol Imaging Radionucl Ther; 2017 Oct; 26(3):116-119. PubMed ID: 28976334
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical Pearls: Etiologies of Superscan Appearance on Fluorine-18-Fludeoxyglucose Positron Emission Tomography-Computed Tomography.
    Manov JJ; Roth PJ; Kuker R
    Indian J Nucl Med; 2017; 32(4):259-265. PubMed ID: 29142340
    [TBL] [Abstract][Full Text] [Related]  

  • 30. "Superscan" appearance in distal renal tubular acidosis.
    Ohashi K; Smith HS; Jacobs MP
    Clin Nucl Med; 1991 May; 16(5):318-20. PubMed ID: 2054985
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unusual Bone Superscan, MIBG Superscan, and 68Ga DOTATATE PET/CT in Metastatic Pheochromocytoma.
    Tan TH; Wong TH; Hassan SZ; Lee BN
    Clin Nucl Med; 2015 Nov; 40(11):867-8. PubMed ID: 26252329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of
    Parghane RV; Singh B; Sharma A; Singh H; Singh P; Bhattacharya A
    J Nucl Med Technol; 2017 Dec; 45(4):280-284. PubMed ID: 28798229
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of whole-body STIR-MRI and 99mTc-methylene-diphosphonate scintigraphy in children with suspected multifocal bone lesions.
    Mentzel HJ; Kentouche K; Sauner D; Fleischmann C; Vogt S; Gottschild D; Zintl F; Kaiser WA
    Eur Radiol; 2004 Dec; 14(12):2297-302. PubMed ID: 15243716
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Parathyroid carcinoma with metastatic calcification identified by technetium-99m methylene diphosphonate scintigraphy.
    Aso Y; Sato A; Tayama K; Takanashi K; Satoh H; Takemura Y
    Intern Med; 1996 May; 35(5):392-5. PubMed ID: 8797054
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An uncommon case showing three different pathologies on (99m)technetium-methylene diphosphonate bone scintigraphy.
    Chakraborty PS; Karunanithi S; Dhull VS; Kumar K; Gupta R; Tripathi M
    Indian J Nucl Med; 2015; 30(1):80-1. PubMed ID: 25589816
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 99Tc(m)(V)DMSA scintigraphy in skeletal metastases and superscans arising from various malignancies: diagnosis, treatment monitoring and therapeutic implications.
    Basu S; Nair N; Awasare S; Tiwari BP; Asopa R; Nair C
    Br J Radiol; 2004 Apr; 77(916):347-61. PubMed ID: 15107330
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical impact and prognostic value of metaiodobenzylguanidine imaging in children with metastatic neuroblastoma.
    Perel Y; Conway J; Kletzel M; Goldman J; Weiss S; Feyler A; Cohn SL
    J Pediatr Hematol Oncol; 1999; 21(1):13-8. PubMed ID: 10029806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic significance of (18)F-FDG and (99m)Tc-methylene diphosphonate uptake in primary osteosarcoma.
    Franzius C; Bielack S; Flege S; Sciuk J; Jürgens H; Schober O
    J Nucl Med; 2002 Aug; 43(8):1012-7. PubMed ID: 12163625
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extraosseous Accumulation of Technetium-99m-Methyl Diphosphonate (
    Banezhad F; Ayati N; Toosi FS; Boloursaz S; Zakavi SR
    Asia Ocean J Nucl Med Biol; 2018; 6(1):57-60. PubMed ID: 29333468
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT.
    Even-Sapir E; Metser U; Mishani E; Lievshitz G; Lerman H; Leibovitch I
    J Nucl Med; 2006 Feb; 47(2):287-97. PubMed ID: 16455635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.